Ypsomed Holding AG Logo

Ypsomed Holding AG (YPSN)

SIX

Currency in CHF
410.00
+5.00 (+1.23%)

Real-time Data

07:00 AM

Day's Range

405.00
410.00

52 wk Range

260.50
419.50

Overview - YPSN - Ypsomed Holding AG

Key Statistics

Valuation

Enterprise Value

5.55B

P/E (Trailing)

‪24.87‬

P/E (Forward)

‪26.81‬

PEG Ratio

‪26.81‬

Price / Sales (TTM)

‪7.28‬

Price / Book

‪6.84‬

EV / EBITDA

‪17.05‬

Profitability

Profit Margin

‪30.36%‬

Operating Margin

‪26.45%‬

Return on Assets

‪12.35%‬

Return on Equity

‪31.08%‬

Ownership

Shares Outstanding

13.14M

Float

3.50M

Held by Insiders

‪74.53%‬

Held by Institutions

‪15.45%‬

Price stats

Beta

‪0.76‬

50-Day Avg

‪376.85‬

200-Day Avg

‪325.97‬

Dividends

Payout Ratio

‪13.50%‬

Frequency

Annual

Peers - YPSN - Ypsomed Holding AG

Peer Comparison

Compared with companies in Medical Instruments & Supplies listed on SIX.

Profile Summary - YPSN - Ypsomed Holding AG

About

Ypsomed Holding AG is a Swiss multinational medical technology company specializing in the development and manufacturing of injection and infusion systems for self-medication. Headquartered in Burgdorf, Switzerland, it emerged in 2003 from the Disetronic Group and focuses primarily on diabetes care and biotechnology…

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees2K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.